NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

The DCVax-L Phase III clinical trial results, for both newly diagnosed GBM (nGBM) and recurrent GBM (rGBM) were exceptional. What does the 13% long-tail overall survival (OS) numbers for newly diagnosed GBM patients mean is real-life? Also, what does the significant increase in the number of nGBM patients in the DCVax-L trial living 24, 36, and 48 months OS mean in real-life?

In the US there are about 13,000 patients per year diagnosed with nGBM. In the EU there are about 22,000 patients per year diagnosed with nGBM. In Canada, 3,000 patients per year diagnosed with nGBM. The total annual nGBM patients in all 4 regions where NWBio conducted the DCVax-L clinical trial is 38,000 nGBM patients per year. I have included some link sbelow to validate these numbers for each region.

These are real people, with real lives, families and loved ones. In the DCVax-L Phase III, 13% of all nGBM treated with DCVax-L were effectively cured (5+ years of complete remission). Based on the annual total number of nGBM patients in the US, UK, Canada, Germany and the rest of the EU, of approximately 38,000 nGBM patients, DCVax-L could effectively cure (5+ years of complete remission) about: 38,000 X 13% = 4,950 potentially cured nGBM patients per year..

In addition to the 13% of nGBM patients that are effectively cured, tens of thousands of the remaining nGBM will experience extended overall survival. The average overall survival for nGBM treated with the current standard of care (tumor resection + chemo + radiotherapy) is 14 to 16 months. More GBM patients in the DCVax-L Phase III trial experienced higher OS to 24, 36 and 48 months, compared to only 14 to 16 months. Every single day of extended life is precious for all GBM patients and their families.

https://braintumor.org/events/glioblastoma-awareness-day/about-glioblastoma/

https://cordis.europa.eu/project/id/780915

https://www.healthing.ca/diseases-and-conditions/cancer/diagnosed-glioblastoma-brain-cancer-diagnosis-bankrupt-families